4.6 Article

CYFIP2, a direct p53 target, is leptomycin-B sensitive

Journal

CELL CYCLE
Volume 6, Issue 1, Pages 95-103

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.6.1.3665

Keywords

differential display; p53 target gene; apoptosis; CYFIP2; PIR121; nucleocytoplasmic shuttling

Categories

Funding

  1. NATIONAL CANCER INSTITUTE [R01CA105024, R01CA076960] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER
  3. NCI NIH HHS [R01 CA76960, CA105024] Funding Source: Medline
  4. NIGMS NIH HHS [GM08554-7] Funding Source: Medline

Ask authors/readers for more resources

A number of target genes for the tumor suppressor, p53, have been identified, however, the mechanisms that contribute to p53-dependent apoptosis remain to be fully elucidated. In a comprehensive screen for p53 target genes, we have identified Cytoplasmic FMR Interacting Protein 2 (CYFIP2) as a p53-inducible gene. Here we show that the CYFIP2 promoter contains a p53-responsive element that confers p53 binding as well as transcriptional activation of a heterologous reporter. Inducible expression of CYFIP2 is sufficient for caspase activation and cellular apoptosis, reminiscent of p53 activation. Together, these results suggest that CYFIP2 is a direct p53 target gene that may be part of a redundant network of genes responsible for p53-dependent apoptosis. In addition, the sensitivity of CYFIP2 protein subcellular localization to Leptomycin-B, a CRM-1/Exportin inhibitor, suggests that the biological functions of CYFIP2 may extend from the cytoplasmic compartment into the nucleus of the cell.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available